A major goal of the Immunology Core is to provide relevant immunologic assays for basic and clinical investigations of HIV and AIDS. The Core will be active in implementing the specific aims of the CFAR which include: 1) further understanding of the immunopathogenesis and pathogenesis of HIV infection and AIDS, 2) provide new approaches toward understanding cellular and humoral immune responses to HIV, 3) determine the effects of different anti-retroviral regimens on reconstitution of immunologic responses to HIV, 3) determine the effects of different anti-retroviral regimens on reconstitution of immunologic responses in HIV-infected subjects; 4) determine the effects of immunotherapy or gene therapy on reconstitution of immunologic responses ro al altering the clinical course in HIV=infected subjects receiving anti-retroviral therapy; 5) develop HIV vaccine strategies. To achieve these aims, standardized, quality-controlled assays of immune function are required to provide useful data for hypothesis testing. The overall goals for this Core are: 1) to provide basic immunology core laboratory support as required by CFAR investigators; 2) to develop new quality-assured assays necessary for CFAR protocols under development or anticipated; 3) to participate actively in the CFASR scientific agenda; 4) to develop standardized protocols for all assays performed in this Core; 5) to participate and demonstrate excellence in laboratory quality assurance and maintain a high standard of performance in established proficiency testing programs; and, 6) to further the understanding of the immunopathogenesis of HIV infection by analysis of data across protocols and by preparation of new concepts for future studies. This core has had substantial experience in cellular immunology research and AIDS research and has demonstrated scientific innovation through past and current scientific contributions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI045008-01
Application #
6167479
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Knecht, Vincent R; McGinniss, John E; Shankar, Hari M et al. (2018) Molecular analysis of bacterial contamination on stethoscopes in an intensive care unit. Infect Control Hosp Epidemiol :1-7
Vujkovic, Marijana; Bellamy, Scarlett L; Zuppa, Athena F et al. (2018) Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana. Pharmacogenomics J 18:678-688
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Grover, Surbhi; Bvochora-Nsingo, Memory; Yeager, Alyssa et al. (2018) Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. Int J Radiat Oncol Biol Phys 101:201-210
Crits-Christoph, Paul; Gallop, Robert; Noll, Elizabeth et al. (2018) Impact of a medical home model on costs and utilization among comorbid HIV-positive Medicaid patients. Am J Manag Care 24:368-375
Sherrill-Mix, Scott; McCormick, Kevin; Lauder, Abigail et al. (2018) Allometry and Ecology of the Bilaterian Gut Microbiome. MBio 9:
Kadimisetty, Karteek; Song, Jinzhao; Doto, Aoife M et al. (2018) Fully 3D printed integrated reactor array for point-of-care molecular diagnostics. Biosens Bioelectron 109:156-163
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Fraietta, Joseph A; Nobles, Christopher L; Sammons, Morgan A et al. (2018) Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558:307-312
Kelly, Matthew S; Surette, Michael G; Smieja, Marek et al. (2018) Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana. Pediatr Infect Dis J 37:1176-1183

Showing the most recent 10 out of 775 publications